{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "解毒效应",
            "expectation": "如存在风险，注明高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_c5_inhibitor",
          "type": "Drug",
          "label": "C5 Inhibitor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_complement_inhibitor",
          "type": "Drug",
          "label": "Complement Inhibitor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_atacicept",
          "type": "Drug",
          "label": "Atacicept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_efgartigimod",
          "type": "Drug",
          "label": "Efgartigimod",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_ahtus",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_c5_inhibitor",
          "type": "Drug",
          "label": "C5 Inhibitor",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_complement_inhibitor",
          "type": "Drug",
          "label": "Complement Inhibitor",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_atacicept",
          "type": "Drug",
          "label": "Atacicept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_efgartigimod",
          "type": "Drug",
          "label": "Efgartigimod",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ishmael",
          "type": "Drug",
          "label": "Ishmael",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_aixin",
          "type": "Drug",
          "label": "Aixin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_c1_inhibitor",
          "type": "Drug",
          "label": "C1 Inhibitor",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_pandemic_influenza_vaccine",
          "type": "Drug",
          "label": "Pandemic Influenza Vaccine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_anti_c5_monoclonal_antibody",
          "type": "Drug",
          "label": "Anti-C5 Monoclonal Antibody",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_lixisenatide",
          "type": "Drug",
          "label": "Lixisenatide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ahus",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "C5 Inhibitor",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Complement Inhibitor",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Atacicept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Efgartigimod",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Ishmael",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_ishmael",
          "type": "Drug",
          "label": "Ishmael",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Aixin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_aixin",
          "type": "Drug",
          "label": "Aixin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "C1 Inhibitor",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_c1_inhibitor",
          "type": "Drug",
          "label": "C1 Inhibitor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Pandemic Influenza Vaccine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_pandemic_influenza_vaccine",
          "type": "Drug",
          "label": "Pandemic Influenza Vaccine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Anti-C5 Monoclonal Antibody",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_anti_c5_monoclonal_antibody",
          "type": "Drug",
          "label": "Anti-C5 Monoclonal Antibody",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Lixisenatide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_lixisenatide",
          "type": "Drug",
          "label": "Lixisenatide",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已在临床上用于治疗该病"
        },
        {
          "source": "drug_ravulizumab",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "机制类似于 Eculizumab，临床应用潜力大"
        },
        {
          "source": "drug_c5_inhibitor",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "靶向相同通路的药物"
        },
        {
          "source": "drug_complement_inhibitor",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "用于调节补体系统，相关性强"
        },
        {
          "source": "drug_atacicept",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "在相关疾病中有潜在疗效"
        },
        {
          "source": "drug_efgartigimod",
          "target": "disease_ahtus",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "正在研究中作为潜在治疗"
        },
        {
          "source": "drug_eculizumab",
          "target": "drug_ravulizumab",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "同类药物机制相似"
        },
        {
          "source": "drug_c5_inhibitor",
          "target": "drug_complement_inhibitor",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "靶向补体系统的相似作用机制"
        },
        {
          "source": "n_eculizumab",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "具有解毒效应"
        },
        {
          "source": "n_ravulizumab",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "与Eculizumab作用机制相似"
        },
        {
          "source": "n_c5_inhibitor",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能通过抑制补体系统发挥作用"
        },
        {
          "source": "n_complement_inhibitor",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "补体抑制可能有益"
        },
        {
          "source": "n_atacicept",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在辅助疗效，需要验证"
        },
        {
          "source": "n_efgartigimod",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "机制尚不明确"
        },
        {
          "source": "n_ishmael",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "缺乏强证据支撑其疗效"
        },
        {
          "source": "n_aixin",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "疗效尚未明确"
        },
        {
          "source": "n_c1_inhibitor",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.4,
          "agent": "Skeptic",
          "rationale": "缺少有效性证明"
        },
        {
          "source": "n_pandemic_influenza_vaccine",
          "target": "n_ahus",
          "relation": "not_indicated_for",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "不适用于此病症"
        },
        {
          "source": "n_anti_c5_monoclonal_antibody",
          "target": "n_ahus",
          "relation": "indicated_for",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能作为替代药物，但缺乏足够研究"
        },
        {
          "source": "n_lixisenatide",
          "target": "n_ahus",
          "relation": "not_indicated_for",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "不适合此类型患者"
        }
      ],
      "round_index": 3
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [
            {
              "id": "n_ot",
              "type": "Target",
              "label": "Detoxification Effect",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_rp",
              "type": "Pathway",
              "label": "Risk Pathway",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_adv",
              "type": "Phenotype",
              "label": "Adverse Effect",
              "attrs": {
                "agent": "Skeptic"
              }
            }
          ],
          "add_edges": [
            {
              "source": "n_eculizumab",
              "target": "n_ot",
              "relation": "acts_on",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "可能导致解毒效应的旁路"
            },
            {
              "source": "n_ot",
              "target": "n_rp",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "关联解毒过程中的风险通路"
            },
            {
              "source": "n_rp",
              "target": "n_adv",
              "relation": "causes",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "可能引发不良效应"
            },
            {
              "source": "n_adv",
              "target": "H1",
              "relation": "refutes",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "如果解毒效应存在危害，将抵消Eculizumab的潜在益处"
            }
          ],
          "merge": [],
          "set_weights": [],
          "conflict_hotspots": [
            {
              "topic": "短期解毒 vs. 长期风险",
              "pro_nodes": [
                "n_eculizumab",
                "n_ravulizumab"
              ],
              "con_nodes": [
                "n_rp",
                "n_adv"
              ],
              "note": "短期使用可能有效但长期风险未评估"
            }
          ]
        },
        "notes": "已完成关于解毒效应的安全性压力测试：将高权重的反驳边连接到假设"
      }
    ],
    "unexecuted_actions": [],
    "residual_conflicts": [
      "解毒效应和长期不良效应之间的冲突尚未解决"
    ]
  }
}